drugset / Trial / NCT00000440

Sertraline and Naltrexone for Alcohol Dependence

NCT00000440

RandomizedDouble-blindTreatment

Summary

This study is a double-blind, placebo-controlled outpatient trial to improve, through the addition of sertraline (Zoloft), the abstinence and relapse rates in alcohol- dependent individuals currently taking naltrexone (Revia).

Timeline

Start
Primary completion
Completion
2002-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Sertraline Small molecule
Background Naltrexone Small molecule

Indications